Literature DB >> 11973494

Comparison of two benzodiazepines used for sedation of children undergoing suturing of a laceration in an emergency department.

Ian J Everitt1, Peter Barnett.   

Abstract

OBJECTIVES: (1) To determine if oral diazepam (POD) is as effective in sedating children less than 6 years of age for laceration repair as oral midazolam (POM) or intranasal midazolam (INM); and (2) To determine if patients stayed longer in the department after sedation when given POD for sedation. DESIGN/
METHODS: Block-randomized, single-blind trial.
SETTING: Tertiary pediatric emergency department. PARTICIPANTS: Patients 1 to 5 years old with a laceration requiring sutures were enrolled.
INTERVENTIONS: All patients had topical anesthetic applied to the wound and were randomly assigned to POD 0.5 mg/kg, POM 1.0 mg/kg, or INM 0.4 mg/kg for sedation.
RESULTS: One hundred twenty-nine patients were enrolled, 42 POD, 45 POM, and 42 INM. Each group was similar at baseline for age, heart rate, respiratory rate, blood pressure, oxygen saturation, previous laceration or sedation, anxiety score, and site of laceration. POM and POD were better tolerated than INM (P = 0.05 and 0.034), respectively. Time to sedation was significantly longer in POD (31.0 +/- 9 min) than INM (26.1 +/- 9 min) (P = 0.011) but there was no significant difference when comparing the other groups. However, this difference was not clinically significant. POD was significantly worse at sedating children compared with POM and INM on all four scores (ie, doctor, nurse, parent, and investigator), but INM and POM were equivalent. Total time in the department was no different between POM and INM or POM and POD, but was significantly different for POD (53.9 +/- 16 min) and INM (48 +/- 12 min); however, this difference was minimal. More patients were said to be drowsy at home in the POM group (51%) than the POD group (32%).
CONCLUSIONS: The oral route of delivery of POM and POD was better tolerated than INM. POM and INM were more effective at sedation than POD, but there was no clinical difference between any groups for time to sedation or time to discharge. More patients in the POM group had side effects after leaving the department. POD may be an alternative to POM, but a higher dose may be required, possibly with longer recovery times.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11973494     DOI: 10.1097/00006565-200204000-00002

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  6 in total

1.  Optimal Volume of Administration of Intranasal Midazolam in Children: A Randomized Clinical Trial.

Authors:  Daniel S Tsze; Maria Ieni; Daniel B Fenster; John Babineau; Joshua Kriger; Bruce Levin; Peter S Dayan
Journal:  Ann Emerg Med       Date:  2016-11-04       Impact factor: 5.721

2.  Mental health services for children in large, employer-based health plans, 1999.

Authors:  Mary Jo Larson; Kay Miller; Kathleen J Fleming; Judith L Teich
Journal:  J Behav Health Serv Res       Date:  2007-01       Impact factor: 1.505

Review 3.  Evaluation of Intranasal Midazolam for Pediatric Sedation during the Suturing of Traumatic Lacerations: A Systematic Review.

Authors:  Francisco Javier Gómez-Manzano; José Alberto Laredo-Aguilera; Ana Isabel Cobo-Cuenca; Joseba Rabanales-Sotos; Sergio Rodríguez-Cañamero; Noelia Martín-Espinosa; Juan Manuel Carmona-Torres
Journal:  Children (Basel)       Date:  2022-04-29

Review 4.  Sedation and Analgesia Using Medications Delivered via the Extravascular Route in Children Undergoing Laceration Repair.

Authors:  Jamie L Miller; Amanda C Capino; Amber Thomas; Kevin Couloures; Peter N Johnson
Journal:  J Pediatr Pharmacol Ther       Date:  2018 Mar-Apr

Review 5.  Midazolam for sedation before procedures.

Authors:  Aaron Conway; John Rolley; Joanna R Sutherland
Journal:  Cochrane Database Syst Rev       Date:  2016-05-20

6.  Efficacy of oral ketamine compared to midazolam for sedation of children undergoing laceration repair: A double-blind, randomized, controlled trial.

Authors:  Orit Rubinstein; Shiri Barkan; Rachelle Breitbart; Sofia Berkovitch; Michal Toledano; Giora Weiser; Natali Karadi; Anat Nassi; Eran Kozer
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.